PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-62.13%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-65.00%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-108.93%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-106.87%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-107.11%
Negative net income growth while RUN stands at 32.57%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-107.05%
Negative EPS growth while RUN is at 32.35%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-108.75%
Negative diluted EPS growth while RUN is at 32.35%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
0.49%
Share change of 0.49% while RUN is at zero. Bruce Berkowitz would see if slight buybacks (or dilution) matter in the bigger picture.
-19.53%
Reduced diluted shares while RUN is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
-192.69%
Negative OCF growth while RUN is at 80.52%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-481.43%
Negative FCF growth while RUN is at 0.68%. Joel Greenblatt would demand improved cost control or more strategic capex discipline.
5.36%
10Y revenue/share CAGR under 50% of RUN's 63.40%. Michael Burry would suspect a lasting competitive disadvantage.
-8.51%
Negative 5Y CAGR while RUN stands at 63.40%. Joel Greenblatt would push for a turnaround plan or reevaluation of the company’s product line.
-24.46%
Negative 3Y CAGR while RUN stands at 63.40%. Joel Greenblatt would look for missteps or fading competitiveness that hurt sales.
83.11%
Positive long-term OCF/share growth while RUN is negative. John Neff would see a structural advantage in sustained cash generation.
-532.42%
Both show negative mid-term OCF/share growth. Martin Whitman might suspect a challenged environment or large capital demands for both.
29.72%
Positive 3Y OCF/share CAGR while RUN is negative. John Neff might see a big short-term edge in operational efficiency.
96.49%
Positive 10Y CAGR while RUN is negative. John Neff might see a substantial advantage in bottom-line trajectory.
-154.92%
Both exhibit negative net income/share growth over five years. Martin Whitman would suspect a challenging environment for the entire niche.
89.12%
Positive short-term CAGR while RUN is negative. John Neff would see a clear advantage in near-term profit trajectory.
No Data
No Data available this quarter, please select a different quarter.
-24.23%
Both show negative equity/share growth mid-term. Martin Whitman suspects cyclical or structural challenges for each company.
1.53%
Positive short-term equity growth while RUN is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Negative near-term dividend growth while RUN invests at 0.00%. Joel Greenblatt sees a weaker short-term distribution policy unless justified by strategic spending.
-11.26%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
45.07%
Inventory growth well above RUN's 48.24%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-5.58%
Negative asset growth while RUN invests at 4.17%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.43%
We have a declining book value while RUN shows 0.48%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-13.00%
We’re deleveraging while RUN stands at 3.08%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-6.85%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
3.64%
SG&A growth well above RUN's 4.64%. Michael Burry sees potential margin erosion unless it translates into higher sales or brand equity.